Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Scott

Showing results (311-320 of 355) with videos related to

Pageof 36
Sort By:
Blood Advances|June 27, 2020
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphomaChristopher K Rushton, Sarah E Arthur, Miguel Alcaide, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2024
Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter ApproachCatalina Amador, Dennis D Weisenburger, Ana Gomez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell LymphomaDaisuke Ennishi, Aixiang Jiang, Merrill Boyle, et al.
Nature|December 10, 2020
Histone H1 loss drives lymphoma by disrupting 3D chromatin architectureNevin Yusufova, Andreas Kloetgen, Matt Teater, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Relapse timing is associated with distinct evolutionary dynamics in DLBCLLaura K Hilton, Henry S Ngu, Brett Collinge, et al.
Science Advances|October 17, 2025
Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroupWaseem G Lone, Jiayu Yu, Xuxiang Liu, et al.
Cancer Cell|September 8, 2025
Large B cell lymphoma microenvironment archetype profilesXubin Li, Kartik Singhal, Qing Deng, et al.
Blood|June 20, 2025
Somatic IRF4 Mutations and Thymic Tropism in Primary Mediastinal Large B-cell LymphomaShinya Rai, Gerben Duns, Fabian Frontzek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2023
Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed/Refractory Hodgkin LymphomaTomohiro Aoki, Aixiang Jiang, Alexander Xu, et al.
Blood Advances|July 29, 2021
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatmentMalgorzata Nowicka, Laura K Hilton, Margaret Ashton-Key, et al.
Pageof 36

Showing results (311-320 of 355) with videos related to

Sort By:
Pageof 36
Blood Advances|June 27, 2020
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphomaChristopher K Rushton, Sarah E Arthur, Miguel Alcaide, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2024
Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter ApproachCatalina Amador, Dennis D Weisenburger, Ana Gomez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 8, 2018
Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell LymphomaDaisuke Ennishi, Aixiang Jiang, Merrill Boyle, et al.
Nature|December 10, 2020
Histone H1 loss drives lymphoma by disrupting 3D chromatin architectureNevin Yusufova, Andreas Kloetgen, Matt Teater, et al.
Medrxiv : the Preprint Server for Health Sciences|March 22, 2023
Relapse timing is associated with distinct evolutionary dynamics in DLBCLLaura K Hilton, Henry S Ngu, Brett Collinge, et al.
Science Advances|October 17, 2025
Cooperative role of distinctive TP53 and PTEN combined loss in the peripheral T cell lymphoma-GATA3 molecular subgroupWaseem G Lone, Jiayu Yu, Xuxiang Liu, et al.
Cancer Cell|September 8, 2025
Large B cell lymphoma microenvironment archetype profilesXubin Li, Kartik Singhal, Qing Deng, et al.
Blood|June 20, 2025
Somatic IRF4 Mutations and Thymic Tropism in Primary Mediastinal Large B-cell LymphomaShinya Rai, Gerben Duns, Fabian Frontzek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2023
Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed/Refractory Hodgkin LymphomaTomohiro Aoki, Aixiang Jiang, Alexander Xu, et al.
Blood Advances|July 29, 2021
Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatmentMalgorzata Nowicka, Laura K Hilton, Margaret Ashton-Key, et al.
Pageof 36